acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

C134H154BBr5N32O9 — CID 157451206

IUPACacetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
SMILESCC(=O)O.CC(C)(C)Nc1ccc(Br)cc1N.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(-c3cnc(N)nc3)ccc21.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C#N)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C(N)=O)nc2cc(Br)ccc21.CC1(C)OB(c2cnc(N)nc2)OC1(C)C.CN(C)/C=N/C(=O)c1ccccc1-c1nc2cc(Br)ccc2n1C(C)(C)C.COC(OC)N(C)C.N#Cc1ccccc1C=O.NN
InChIInChI=1S/C23H22N8.C21H23BrN4O.C19H18BrN5.C18H18BrN3O.C18H16BrN3.C10H16BN3O2.C10H15BrN2.C8H5NO.C5H13NO2.C2H4O2.H4N2/c1-23(2,3)31-19-9-8-14(15-11-25-22(24)26-12-15)10-18(19)29-21(31)17-7-5-4-6-16(17)20-27-13-28-30-20;1-21(2,3)26-18-11-10-14(22)12-17(18)24-19(26)15-8-6-7-9-16(15)20(27)23-13-25(4)5;1-19(2,3)25-16-9-8-12(20)10-15(16)23-18(25)14-7-5-4-6-13(14)17-21-11-22-24-17;1-18(2,3)22-15-9-8-11(19)10-14(15)21-17(22)13-7-5-4-6-12(13)16(20)23;1-18(2,3)22-16-9-8-13(19)10-15(16)21-17(22)14-7-5-4-6-12(14)11-20;1-9(2)10(3,4)16-11(15-9)7-5-13-8(12)14-6-7;1-10(2,3)13-9-5-4-7(11)6-8(9)12;9-5-7-3-1-2-4-8(7)6-10;1-6(2)5(7-3)8-4;1-2(3)4;1-2/h4-13H,1-3H3,(H2,24,25,26)(H,27,28,30);6-13H,1-5H3;4-11H,1-3H3,(H,21,22,24);4-10H,1-3H3,(H2,20,23);4-10H,1-3H3;5-6H,1-4H3,(H2,12,13,14);4-6,13H,12H2,1-3H3;1-4,6H;5H,1-4H3;1H3,(H,3,4);1-2H2/b;23-13+;;;;;;;;;
InChIKeyOTZVIVUBESZSOH-NJXJCLFTSA-N
MW2767.25 g/mol
LogP27.66
Rot. Bonds17

About acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (PubChem CID 157451206) has the molecular formula C134H154BBr5N32O9 and a molecular weight of 2767.25 g/mol. Its IUPAC name is acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine.

Molecular Properties

Compound Nameacetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
PubChem CID157451206
Molecular FormulaC134H154BBr5N32O9
Molecular Weight2767.25 g/mol
Exact Mass2760.86
IUPAC Nameacetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
SMILESCC(=O)O.CC(C)(C)Nc1ccc(Br)cc1N.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(-c3cnc(N)nc3)ccc21.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C#N)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C(N)=O)nc2cc(Br)ccc21.CC1(C)OB(c2cnc(N)nc2)OC1(C)C.CN(C)/C=N/C(=O)c1ccccc1-c1nc2cc(Br)ccc2n1C(C)(C)C.COC(OC)N(C)C.N#Cc1ccccc1C=O.NN
InChIInChI=1S/C23H22N8.C21H23BrN4O.C19H18BrN5.C18H18BrN3O.C18H16BrN3.C10H16BN3O2.C10H15BrN2.C8H5NO.C5H13NO2.C2H4O2.H4N2/c1-23(2,3)31-19-9-8-14(15-11-25-22(24)26-12-15)10-18(19)29-21(31)17-7-5-4-6-16(17)20-27-13-28-30-20;1-21(2,3)26-18-11-10-14(22)12-17(18)24-19(26)15-8-6-7-9-16(15)20(27)23-13-25(4)5;1-19(2,3)25-16-9-8-12(20)10-15(16)23-18(25)14-7-5-4-6-13(14)17-21-11-22-24-17;1-18(2,3)22-15-9-8-11(19)10-14(15)21-17(22)13-7-5-4-6-12(13)16(20)23;1-18(2,3)22-16-9-8-13(19)10-15(16)21-17(22)14-7-5-4-6-12(14)11-20;1-9(2)10(3,4)16-11(15-9)7-5-13-8(12)14-6-7;1-10(2,3)13-9-5-4-7(11)6-8(9)12;9-5-7-3-1-2-4-8(7)6-10;1-6(2)5(7-3)8-4;1-2(3)4;1-2/h4-13H,1-3H3,(H2,24,25,26)(H,27,28,30);6-13H,1-5H3;4-11H,1-3H3,(H,21,22,24);4-10H,1-3H3,(H2,20,23);4-10H,1-3H3;5-6H,1-4H3,(H2,12,13,14);4-6,13H,12H2,1-3H3;1-4,6H;5H,1-4H3;1H3,(H,3,4);1-2H2/b;23-13+;;;;;;;;;
InChIKeyOTZVIVUBESZSOH-NJXJCLFTSA-N
XLogP27.66
TPSA583.80 Ų
H-Bond Donors10
H-Bond Acceptors35
Rotatable Bonds17
Heavy Atoms181
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002767.25
LogP ≤ 527.66
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}

Analyze acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;2-bromobenzaldehyde;5-[1-tert-butyl-2-[2-(1H-pyrazol-4-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;2-(1H-pyrazol-4-yl)benzaldehyde;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CID 157671163
acetic acid;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-[1-(dimethylamino)ethylidene]benzamide;5-bromo-1-tert-butyl-2-[2-(5-methyl-1H-1,2,4-triazol-3-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(5-methyl-1H-pyrazol-3-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylethanamine;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
CID 159015429
acetic acid;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-[1-(dimethylamino)ethylidene]benzamide;5-bromo-1-tert-butyl-2-[2-(5-methyl-1H-1,2,4-triazol-3-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(5-methyl-1H-1,2,4-triazol-3-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylethanamine;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
CID 160500913
4-(2-aminopyrimidin-5-yl)-1-N-tert-butylbenzene-1,2-diamine;2-bromobenzaldehyde;5-[2-(2-bromophenyl)-1-tert-butylbenzimidazol-5-yl]pyrimidin-2-amine;5-[1-tert-butyl-2-[2-(1-methylpyrazol-4-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
CID 161447552
1-[3-[2-[5-(2-aminopyrimidin-5-yl)-1-tert-butylbenzimidazol-2-yl]phenyl]-1,2,4-oxadiazol-5-yl]propan-1-one;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N'-hydroxybenzenecarboximidamide;1-[3-[2-(5-bromo-1-tert-butylbenzimidazol-2-yl)phenyl]-1,2,4-oxadiazol-5-yl]propan-1-one;2-formylbenzonitrile;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
CID 161554695

Frequently Asked Questions

What is the IUPAC name of acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine?
The IUPAC name of acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (CID 157451206) is acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine.
What is the SMILES notation for acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine?
The canonical SMILES for acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine is CC(=O)O.CC(C)(C)Nc1ccc(Br)cc1N.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(-c3cnc(N)nc3)ccc21.CC(C)(C)n1c(-c2ccccc2-c2ncn[nH]2)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C#N)nc2cc(Br)ccc21.CC(C)(C)n1c(-c2ccccc2C(N)=O)nc2cc(Br)ccc21.CC1(C)OB(c2cnc(N)nc2)OC1(C)C.CN(C)/C=N/C(=O)c1ccccc1-c1nc2cc(Br)ccc2n1C(C)(C)C.COC(OC)N(C)C.N#Cc1ccccc1C=O.NN.
What is the InChIKey of acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine?
The InChIKey is OTZVIVUBESZSOH-NJXJCLFTSA-N. The full InChI is InChI=1S/C23H22N8.C21H23BrN4O.C19H18BrN5.C18H18BrN3O.C18H16BrN3.C10H16BN3O2.C10H15BrN2.C8H5NO.C5H13NO2.C2H4O2.H4N2/c1-23(2,3)31-19-9-8-14(15-11-25-22(24)26-12-15)10-18(19)29-21(31)17-7-5-4-6-16(17)20-27-13-28-30-20;1-21(2,3)26-18-11-10-14(22)12-17(18)24-19(26)15-8-6-7-9-16(15)20(27)23-13-25(4)5;1-19(2,3)25-16-9-8-12(20)10-15(16)23-18(25)14-7-5-4-6-13(14)17-21-11-22-24-17;1-18(2,3)22-15-9-8-11(19)10-14(15)21-17(22)13-7-5-4-6-12(13)16(20)23;1-18(2,3)22-16-9-8-13(19)10-15(16)21-17(22)14-7-5-4-6-12(14)11-20;1-9(2)10(3,4)16-11(15-9)7-5-13-8(12)14-6-7;1-10(2,3)13-9-5-4-7(11)6-8(9)12;9-5-7-3-1-2-4-8(7)6-10;1-6(2)5(7-3)8-4;1-2(3)4;1-2/h4-13H,1-3H3,(H2,24,25,26)(H,27,28,30);6-13H,1-5H3;4-11H,1-3H3,(H,21,22,24);4-10H,1-3H3,(H2,20,23);4-10H,1-3H3;5-6H,1-4H3,(H2,12,13,14);4-6,13H,12H2,1-3H3;1-4,6H;5H,1-4H3;1H3,(H,3,4);1-2H2/b;23-13+;;;;;;;;;.
What are the key properties of acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine?
acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine has a molecular weight of 2767.25 g/mol, XLogP of 27.66, 17 rotatable bonds, 10 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for acetic acid;4-bromo-1-N-tert-butylbenzene-1,2-diamine;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzamide;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)benzonitrile;2-(5-bromo-1-tert-butylbenzimidazol-2-yl)-N-(dimethylaminomethylidene)benzamide;5-bromo-1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazole;5-[1-tert-butyl-2-[2-(1H-1,2,4-triazol-5-yl)phenyl]benzimidazol-5-yl]pyrimidin-2-amine;1,1-dimethoxy-N,N-dimethylmethanamine;2-formylbenzonitrile;hydrazine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine is sourced from PubChem (CID 157451206), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).